These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34657382)

  • 1. Effect of p53 and its N-terminally truncated isoform, Δ40p53, on breast cancer migration and invasion.
    Zhang X; Groen K; Morten BC; Steffens Reinhardt L; Campbell HG; Braithwaite AW; Bourdon JC; Avery-Kiejda KA
    Mol Oncol; 2022 Jan; 16(2):447-465. PubMed ID: 34657382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer.
    Steffens Reinhardt L; Groen K; Zhang X; Morten BC; Wawruszak A; Avery-Kiejda KA
    Cell Death Dis; 2023 Aug; 14(8):509. PubMed ID: 37553320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage.
    Steffens Reinhardt L; Zhang X; Groen K; Morten BC; De Iuliis GN; Braithwaite AW; Bourdon JC; Avery-Kiejda KA
    Cell Death Dis; 2022 Oct; 13(10):907. PubMed ID: 36307393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer.
    Hofstetter G; Berger A; Berger R; Zorić A; Braicu EI; Reimer D; Fiegl H; Marth C; Zeimet AG; Ulmer H; Moll U; Zeillinger R; Concin N
    Int J Gynecol Cancer; 2012 Mar; 22(3):372-9. PubMed ID: 22246403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of miR-186-YY1 axis by the p53 translational isoform ∆40p53: implications in cell proliferation.
    Katoch A; Tripathi SK; Pal A; Das S
    Cell Cycle; 2021; 20(5-6):561-574. PubMed ID: 33629930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the QuantiGene 2.0 Assay and Real-Time RT-PCR in the Detection of p53 Isoform mRNA Expression in Formalin-Fixed Paraffin-Embedded Tissues- A Preliminary Study.
    Morten BC; Scott RJ; Avery-Kiejda KA
    PLoS One; 2016; 11(11):e0165930. PubMed ID: 27832134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "LINC" between Δ40p53-miRNA Axis in the Regulation of Cellular Homeostasis.
    Pal A; Ghosh PK; Das S
    Mol Cell Biol; 2023; 43(7):335-353. PubMed ID: 37283188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs.
    Ungewitter E; Scrable H
    Genes Dev; 2010 Nov; 24(21):2408-19. PubMed ID: 21041409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Δ40p53 isoform up-regulates netrin-1/UNC5B expression and potentiates netrin-1 pro-oncogenic activity.
    Sun Y; Manceau A; Frydman L; Cappuccio L; Neves D; Basso V; Wang H; Fombonne J; Maisse C; Mehlen P; Paradisi A
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34470826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome.
    Morten BC; Wong-Brown MW; Scott RJ; Avery-Kiejda KA
    Carcinogenesis; 2016 Jan; 37(1):81-86. PubMed ID: 26586794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.
    Avery-Kiejda KA; Morten B; Wong-Brown MW; Mathe A; Scott RJ
    Carcinogenesis; 2014 Mar; 35(3):586-96. PubMed ID: 24336193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Δ40p53 isoform on enhancing the pro-apoptotic function of p53 in tumor cells].
    Wang BS; Zhao HW; Qiao LX; Shan JQ; Hou QS; Chen DX; Guo HL
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):332-338. PubMed ID: 28535648
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.
    Guttery DS; Hancox RA; Mulligan KT; Hughes S; Lambe SM; Pringle JH; Walker RA; Jones JL; Shaw JA
    Breast Cancer Res; 2010; 12(4):R57. PubMed ID: 20678196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
    Oh L; Hainaut P; Blanchet S; Ariffin H
    BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.
    Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK
    BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.
    Guo Y; Wu H; Wiesmüller L; Chen M
    Cell Death Dis; 2024 Jun; 15(6):412. PubMed ID: 38866752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant effects of Δ40p53 on p53 function and melanoma cell fate.
    Takahashi R; Markovic SN; Scrable HJ
    J Invest Dermatol; 2014 Mar; 134(3):791-800. PubMed ID: 24037342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
    Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
    Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.
    Hafsi H; Santos-Silva D; Courtois-Cox S; Hainaut P
    BMC Cancer; 2013 Mar; 13():134. PubMed ID: 23514281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.